Schnell Oliver, Klausmann Gerd, Gutschek Bettina, Garcia-Verdugo Rosa Maria, Hummel Michael
1 Sciarc Institute, Baierbrunn, Germany.
2 Forschergruppe Diabetes e.V., Munich-Neuherberg, Germany.
J Diabetes Sci Technol. 2017 Nov;11(6):1218-1225. doi: 10.1177/1932296817706376. Epub 2017 Apr 26.
Self-monitoring of blood glucose (SMBG) is a key pillar of personal diabetes management. The objective of this observational study was to analyze diabetes self-management (DSM) and glycemic outcomes before and during system implementation in real-life settings of a blood glucose meter system with a color-coded display of glucose levels, which helps identify out-of-range levels.
A total of 193 insulin-treated diabetes patients (11% T1DM; 55% male, age 60 ± 4 years, mean diabetes duration 14 ± 9 years, HbA1c 8.68 ± 1.2%) were enrolled into the study. Both the Diabetes Self-Management Questionnaire (DSMQ) and glycemic control were analyzed at baseline and 3 and 6 months after study initiation.
DSMQ general perception improved significantly by the end of the study period ("Sum Scale," P < .05). Moreover, after 6 months patient's attitudes on self-care (Q16, P = .0046) and nutrition ("Dietary Control," P = .004) showed significant improvements. Use of the blood glucose meter resulted in improved glycemic control, as shown by mean HbA1c levels, which decreased from 8.68 ± 1.2% at baseline to 8.13 ± 1.02% after 3 months ( P < .0001) and to 7.9 ± 1.1% at 6 months ( P < .0001). Both patients and diabetes educators agreed in the advantages of the color-coded indicator and on its helpfulness in assisting patients on their diabetes management, as drawn from the results of the self-reported satisfaction questionnaire.
This real-world study demonstrates that SMBG implemented via this new blood glucose meter not only leads to an improvement in metabolic control, but also is associated with a significant improvement in diabetes management.
血糖自我监测(SMBG)是个人糖尿病管理的关键支柱。这项观察性研究的目的是分析在具有血糖水平颜色编码显示的血糖仪系统的实际应用场景中,系统实施前和实施期间的糖尿病自我管理(DSM)及血糖结果,该显示有助于识别超出范围的血糖水平。
共有193例接受胰岛素治疗的糖尿病患者(11%为1型糖尿病;55%为男性,年龄60±4岁,平均糖尿病病程14±9年,糖化血红蛋白8.68±1.2%)纳入该研究。在基线以及研究开始后3个月和6个月时,对糖尿病自我管理问卷(DSMQ)和血糖控制情况进行分析。
到研究期结束时,DSMQ总体认知有显著改善(“总和量表”,P<.05)。此外,6个月后患者在自我护理方面的态度(问题16,P = .0046)和营养方面(“饮食控制”,P = .004)有显著改善。血糖仪的使用使血糖控制得到改善,糖化血红蛋白平均水平从基线时的8.68±1.2%降至3个月后的8.13±1.02%(P<.0001),并在6个月时降至7.9±1.1%(P<.0001)。从自我报告满意度问卷的结果来看,患者和糖尿病教育者都认同颜色编码指示器的优点及其在协助患者进行糖尿病管理方面的帮助作用。
这项实际应用研究表明,通过这种新型血糖仪实施的血糖自我监测不仅能改善代谢控制,还与糖尿病管理的显著改善相关。